Search research articles
Contact Us
Filters
Showing results (151-160 of 185) with videos related to
Page
of 19
Sort By:
Plos One
|
March 3, 2011
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
Espen Enerly, Israel Steinfeld, Kristine Kleivi, et al.
Antiviral Research
|
January 25, 2024
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome
Mariia S Bogacheva, Suvi Kuivanen, Swapnil Potdar, et al.
Journal of Proteome Research
|
November 11, 2011
Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling
Scarlet F Brockmöller, Elmar Bucher, Berit M Müller, et al.
NPJ Precision Oncology
|
July 24, 2021
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia
Brian S White, Suleiman A Khan, Mike J Mason, et al.
Antimicrobial Agents and Chemotherapy
|
April 23, 2014
Akt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro
Oxana V Denisova, Sandra Söderholm, Salla Virtanen, et al.
Journal of Proteome Research
|
June 1, 2022
Correction to "Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer─Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling"
Scarlet F Brockmöller, Elmar Bucher, Berit M Müller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2018
Anagrelide for Gastrointestinal Stromal Tumor
Olli-Pekka Pulkka, Yemarshet K Gebreyohannes, Agnieszka Wozniak, et al.
British Journal of Cancer
|
February 13, 2019
Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas
Bertha A Brodin, Krister Wennerberg, Elisabet Lidbrink, et al.
Communications Biology
|
October 19, 2024
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma
Matilda Roos-Mattila, Pauliina Kallio, Tamara J Luck, et al.
Nature Genetics
|
November 26, 2002
High frequency of BRAF mutations in nevi
Pamela M Pollock, Ursula L Harper, Katherine S Hansen, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 185) with videos related to
Sort By:
Page
of 19
Plos One
|
March 3, 2011
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
Espen Enerly, Israel Steinfeld, Kristine Kleivi, et al.
Antiviral Research
|
January 25, 2024
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome
Mariia S Bogacheva, Suvi Kuivanen, Swapnil Potdar, et al.
Journal of Proteome Research
|
November 11, 2011
Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling
Scarlet F Brockmöller, Elmar Bucher, Berit M Müller, et al.
NPJ Precision Oncology
|
July 24, 2021
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia
Brian S White, Suleiman A Khan, Mike J Mason, et al.
Antimicrobial Agents and Chemotherapy
|
April 23, 2014
Akt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro
Oxana V Denisova, Sandra Söderholm, Salla Virtanen, et al.
Journal of Proteome Research
|
June 1, 2022
Correction to "Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer─Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling"
Scarlet F Brockmöller, Elmar Bucher, Berit M Müller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2018
Anagrelide for Gastrointestinal Stromal Tumor
Olli-Pekka Pulkka, Yemarshet K Gebreyohannes, Agnieszka Wozniak, et al.
British Journal of Cancer
|
February 13, 2019
Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas
Bertha A Brodin, Krister Wennerberg, Elisabet Lidbrink, et al.
Communications Biology
|
October 19, 2024
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma
Matilda Roos-Mattila, Pauliina Kallio, Tamara J Luck, et al.
Nature Genetics
|
November 26, 2002
High frequency of BRAF mutations in nevi
Pamela M Pollock, Ursula L Harper, Katherine S Hansen, et al.
Page
of 19